E06.2
Chronic thyroiditis with transient thyrotoxicosis
Clinical Classification Guidelines
Excludes Type 1
- autoimmune thyroiditis (E06.3)
Medical Intelligence & Overview
Chronic thyroiditis with transient thyrotoxicosis, also known as Hashimoto's thyroiditis with temporary hyperthyroidism, is a long-term autoimmune condition affecting the thyroid gland. The condition involves the gradual destruction of thyroid tissue by the immune system, which can sometimes cause a temporary phase of excess thyroid hormone release, leading to symptoms of hyperthyroidism before settling into a hypothyroid state. Recognizing and understanding this condition can help in managing its symptoms and complications effectively.
Causes & Symptoms
Clinical Causes: Autoimmune response: The immune system mistakenly attacks the thyroid gland, resulting in inflammation and gland destruction. Genetic predisposition: A family history of autoimmune thyroid diseases increases risk. Environmental factors: Exposure to certain viruses and excessive iodine intake may contribute. Other autoimmune conditions: Presence of other autoimmune disorders can increase susceptibility.
Key Symptoms: Initial phase of hyperthyroidism may include: - Nervousness or anxiety - Rapid heartbeat (tachycardia) - Increased sweating - Weight loss despite increased appetite - Tremors or shaking - Heat intolerance - Fatigue or muscle weakness - Sleep disturbances As the disease progresses, symptoms of hypothyroidism may develop, such as: - Fatigue or tiredness - Weight gain - Cold intolerance - Dry skin - Constipation - Depression or mood changes - Memory problems or difficulty concentrating
Diagnostic & Treatment
Diagnosis Path: Medical history assessment focusing on symptoms and family history. Physical examination of the thyroid gland for enlargement or tenderness. Blood tests to measure levels of thyroid hormones (T3 and T4) and thyroid-stimulating hormone (TSH). Autoantibody tests, such as anti-thyroid peroxidase (anti-TPO) antibodies and anti-thyroglobulin antibodies, indicating autoimmune activity. Radioactive iodine uptake test to evaluate thyroid function and distinguish between different types of thyroiditis. Ultrasound imaging of the thyroid gland to assess size, texture, and presence of nodules.
Treatment Protocols: Monitoring: Regular follow-up with thyroid function tests to track disease progression. Medications: – Beta-blockers (e.g., propranolol): To control symptoms of hyperthyroidism such as rapid heartbeat and tremors during transient thyrotoxicosis. – Levothyroxine: To replace thyroid hormone if hypothyroidism develops later. Addressing inflammation: In some cases, corticosteroids may be used to reduce thyroid inflammation. Lifestyle adjustments: Nutritional and lifestyle modifications to manage symptoms and overall health. Surgical intervention: Rarely needed, but may be considered if there are significant goiter symptoms or suspicion of malignancy. Note: Treatment plans are individualized, and it’s essential to consult healthcare providers for proper management.
Clinical Advice & FAQs
Billing Guidance
Is E06.2 a billable ICD-10 code?
Yes, E06.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E06.2?
Clinical documentation must specify the nature of Chronic thyroiditis with transient thyrotoxicosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference